Association of Interferon- and Transforming Growth Factor beta-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCHRISTMANN, Romy B.
dc.contributor.authorSAMPAIO-BARROS, Percival
dc.contributor.authorSTIFANO, Giuseppina
dc.contributor.authorBORGES, Claudia L.
dc.contributor.authorCARVALHO, Carlos R. de
dc.contributor.authorKAIRALLA, Ronaldo
dc.contributor.authorPARRA, Edwin R.
dc.contributor.authorSPIRA, Avrum
dc.contributor.authorSIMMS, Robert
dc.contributor.authorCAPELLOZZI, Vera L.
dc.contributor.authorLAFYATIS, Robert
dc.date.accessioned2014-09-30T14:55:05Z
dc.date.available2014-09-30T14:55:05Z
dc.date.issued2014
dc.description.abstractObjective. Systemic sclerosis (SSc)-related interstitial lung disease (ILD) is one of the leading causes of mortality. We undertook this study to analyze the gene expression of lung tissue in a prospective cohort of patients with SSc-related ILD and to compare it with that in control lungs and with 2 prospective clinical parameters in order to understand the molecular pathways implicated in progressive lung disease. Methods. Lung tissue was obtained by open lung biopsy in 28 consecutive patients with SSc-related ILD and in 4 controls. High-resolution computed tomography (HRCT) and pulmonary function testing (PFT) were performed at baseline and 2-3 years after treatment based on lung histologic classification. Microarray analysis was performed, and the results were correlated with changes in the HRCT score (FibMax) and PFT values. Quantitative polymerase chain reaction (qPCR) and immunohistochemistry were used to confirm differential levels of messenger RNA and protein. Results. Lung microarray data distinguished patients with SSc-related ILD from healthy controls. In the lungs of patients with SSc-related ILD who had nonspecific interstitial pneumonia (NSIP), expressed genes included macrophage markers, chemokines, collagen, and transforming growth factor beta (TGF beta)- and interferon (IFN)-regulated genes. Expression of these genes correlated with progressive lung fibrosis defined by the change in FibMax. Immunohistochemistry confirmed increased markers of collagen (COL1A1), IFN (OAS1 and IFI44), and macrophages (CCL18 and CD163), and the positive correlation with the change in FibMax was confirmed by qPCR in a larger group of SSc patients with NSIP. Several genes correlated with both the change in FibMax (r > 0.4) and the change in % predicted forced vital capacity (r < -0.1), including IFN and macrophage markers, chemokines, and heat-shock proteins. Conclusion. These results highlight major pathogenic pathways relevant to progressive pulmonary fibrosis in SSc-related ILD: macrophage emigration and activation, and up-regulated expression of TGF beta- and IFN-regulated genes.
dc.description.indexWoS
dc.description.sponsorshipNIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS] Center of Research Translation [1-P50-AR-060780-01]
dc.description.sponsorshipNIH (NIAMS) [2-R01-AR-051089-06A1]
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)
dc.identifier.citationARTHRITIS & RHEUMATOLOGY, v.66, n.3, p.714-725, 2014
dc.identifier.doi10.1002/art.38288
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/7785
dc.language.isoeng
dc.publisherWILEY-BLACKWELL
dc.relation.ispartofArthritis & Rheumatology
dc.rightsrestrictedAccess
dc.rights.holderCopyright WILEY-BLACKWELL
dc.subject.otheridiopathic pulmonary-fibrosis
dc.subject.othercentrilobular fibrosis
dc.subject.othercirculating monocytes
dc.subject.otherscleroderma
dc.subject.otherdisease
dc.subject.otherexpression
dc.subject.otherchemokine
dc.subject.otheralpha
dc.subject.othersubsets
dc.subject.otherdeath
dc.subject.wosRheumatology
dc.titleAssociation of Interferon- and Transforming Growth Factor beta-Regulated Genes and Macrophage Activation With Systemic Sclerosis-Related Progressive Lung Fibrosis
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.author.externalCHRISTMANN, Romy B.:Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
hcfmusp.author.externalSTIFANO, Giuseppina:Boston Univ, Sch Med, Boston, MA 02118 USA
hcfmusp.author.externalBORGES, Claudia L.:Univ Sao Luis do Maranhao, CEUMA, Sao Luis, MA, Brazil
hcfmusp.author.externalCARVALHO, Carlos R. de:Univ Sao Luis do Maranhao, CEUMA, Sao Luis, MA, Brazil
hcfmusp.author.externalKAIRALLA, Ronaldo:Univ Sao Luis do Maranhao, CEUMA, Sao Luis, MA, Brazil
hcfmusp.author.externalPARRA, Edwin R.:Univ Sao Luis do Maranhao, CEUMA, Sao Luis, MA, Brazil
hcfmusp.author.externalSPIRA, Avrum:Boston Univ, Sch Med, Boston, MA 02118 USA
hcfmusp.author.externalSIMMS, Robert:Boston Univ, Sch Med, Boston, MA 02118 USA
hcfmusp.author.externalCAPELLOZZI, Vera L.:Univ Sao Luis do Maranhao, CEUMA, Sao Luis, MA, Brazil
hcfmusp.author.externalLAFYATIS, Robert:Boston Univ, Sch Med, Boston, MA 02118 USA
hcfmusp.citation.scopus167
hcfmusp.contributor.author-fmusphcPERCIVAL DEGRAVA SAMPAIO BARROS
hcfmusp.description.beginpage714
hcfmusp.description.endpage725
hcfmusp.description.issue3
hcfmusp.description.volume66
hcfmusp.origemWOS
hcfmusp.origem.pubmed24574232
hcfmusp.origem.scopus2-s2.0-84896287076
hcfmusp.origem.wosWOS:000337359400028
hcfmusp.publisher.cityHOBOKEN
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAgusti C, 2002, AM J RESP CRIT CARE, V166, P426
hcfmusp.relation.referenceAssassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125
hcfmusp.relation.referenceAtamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC
hcfmusp.relation.referenceATS/ERS, 2002, AM J RESP CRIT CARE, V165, P277
hcfmusp.relation.referenceBerkman N, 2001, RESPIRATION, V68, P169, DOI 10.1159/000050488
hcfmusp.relation.referenceBerkman N, 1997, LIFE SCI, V60, pPL415
hcfmusp.relation.referenceCASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401
hcfmusp.relation.referenceCATOGGIO LJ, 1983, ANN RHEUM DIS, V42, P23, DOI 10.1136/ard.42.1.23
hcfmusp.relation.referenceChristmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318
hcfmusp.relation.referenceCLEMENTS P, 1995, J RHEUMATOL, V22, P1281
hcfmusp.relation.referencede Carvalho MEP, 2002, PATHOL RES PRACT, V198, P577, DOI 10.1078/0344-0338-00305
hcfmusp.relation.referencede Souza RBC, 2009, RESPIRATION, V77, P389, DOI 10.1159/000156958
hcfmusp.relation.referenceEloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400
hcfmusp.relation.referenceFarina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850
hcfmusp.relation.referenceFurst DE, 1998, J RHEUMATOL, V25, P84
hcfmusp.relation.referenceGibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC
hcfmusp.relation.referenceGoh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC
hcfmusp.relation.referenceGoldin JG, 2008, CHEST, V134, P358, DOI 10.1378/chest.07-2444
hcfmusp.relation.referenceHoyles RK, 2006, ARTHRITIS RHEUM, V54, P3962, DOI 10.1002/art.22204
hcfmusp.relation.referenceHsu E, 2011, ARTHRITIS RHEUM-US, V63, P783, DOI 10.1002/art.30159
hcfmusp.relation.referenceIoannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031
hcfmusp.relation.referenceJIMENEZ SA, 1984, J CLIN INVEST, V74, P1112, DOI 10.1172/JCI111480
hcfmusp.relation.referenceKim D, 2008, ARTHRITIS RHEUM, V58, P2163, DOI 10.1002/art.23486
hcfmusp.relation.referenceLEROY EC, 1988, J RHEUMATOL, V15, P202
hcfmusp.relation.referenceLuzina IG, 2002, AM J RESP CELL MOL, V26, P549
hcfmusp.relation.referenceMathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73
hcfmusp.relation.referenceMilano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696
hcfmusp.relation.referenceMorgan C, 2003, ANN RHEUM DIS, V62, P146, DOI 10.1136/ard.62.2.146
hcfmusp.relation.referenceMurray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI [10.1016/j.biocel.2010.10.013, 10.1016/j.bioce1.2010.10.013]
hcfmusp.relation.referencePawluk-Kolc M, 2006, FORENSIC SCI INT, V160, P53, DOI 10.1016/j.forsciint.2005.08.016
hcfmusp.relation.referencePechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017
hcfmusp.relation.referencePendergrass SA, PLOS ONE, V5
hcfmusp.relation.referencePeng Xueyan, 2011, Fibrogenesis Tissue Repair, V4, P12, DOI 10.1186/1755-1536-4-12
hcfmusp.relation.referencePrassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC
hcfmusp.relation.referencePrasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC
hcfmusp.relation.referenceRoth MD, 2011, ARTHRITIS RHEUM-US, V63, P2797, DOI 10.1002/art.30438
hcfmusp.relation.referenceSampaio-Barros PD, 2012, J RHEUMATOL, V39, P1971, DOI 10.3899/jrheum.111582
hcfmusp.relation.referenceSchraufstatter I, 2004, AM J PHYSIOL-LUNG C, V286, pL494, DOI 10.1152/ajplung.00323.2002
hcfmusp.relation.referenceSchutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712
hcfmusp.relation.referenceSelman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC
hcfmusp.relation.referenceSteen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068
hcfmusp.relation.referenceSubcommittee for Scleroderma Criteria of the American Rheumatism. Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581
hcfmusp.relation.referenceTashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120
hcfmusp.relation.referenceTiev KP, 2011, EUR RESPIR J, V38, P1355, DOI 10.1183/09031936.00004711
hcfmusp.relation.referenceTyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264
hcfmusp.relation.referenceWynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551
hcfmusp.relation.referenceYork MR, 2007, ARTHRITIS RHEUM, V56, P1010, DOI 10.1002/art.22382
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.remissive.sponsorshipNIH
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication543b5865-d037-4c2e-8a6b-28f77f9e9e8e
relation.isAuthorOfPublication.latestForDiscovery543b5865-d037-4c2e-8a6b-28f77f9e9e8e
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CHRISTMANN_Association_of_Interferon_and_Transforming_Growth_Factor_beta_2014.PDF
Tamanho:
1.23 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)